These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30184299)

  • 1. Progesterone and plasma metabolites in women with and in those without premenstrual dysphoric disorder.
    Di Florio A; Alexander D; Schmidt PJ; Rubinow DR
    Depress Anxiety; 2018 Dec; 35(12):1168-1177. PubMed ID: 30184299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The steroid metabolome in women with premenstrual dysphoric disorder during GnRH agonist-induced ovarian suppression: effects of estradiol and progesterone addback.
    Nguyen TV; Reuter JM; Gaikwad NW; Rotroff DM; Kucera HR; Motsinger-Reif A; Smith CP; Nieman LK; Rubinow DR; Kaddurah-Daouk R; Schmidt PJ
    Transl Psychiatry; 2017 Aug; 7(8):e1193. PubMed ID: 28786978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Premenstrual Dysphoric Disorder Symptoms Following Ovarian Suppression: Triggered by Change in Ovarian Steroid Levels But Not Continuous Stable Levels.
    Schmidt PJ; Martinez PE; Nieman LK; Koziol DE; Thompson KD; Schenkel L; Wakim PG; Rubinow DR
    Am J Psychiatry; 2017 Oct; 174(10):980-989. PubMed ID: 28427285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotrophic hormone and reinforcement sensitivity systems in women with premenstrual dysphoric disorder.
    Ko CH; Long CY; Yen CF; Chen CS; Wang PW; Yen JY
    Psychiatry Clin Neurosci; 2014 Nov; 68(11):785-94. PubMed ID: 24735107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early- and Late-Luteal-Phase Estrogen and Progesterone Levels of Women with Premenstrual Dysphoric Disorder.
    Yen JY; Lin HC; Lin PC; Liu TL; Long CY; Ko CH
    Int J Environ Res Public Health; 2019 Nov; 16(22):. PubMed ID: 31703451
    [No Abstract]   [Full Text] [Related]  

  • 6. 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder.
    Martinez PE; Rubinow DR; Nieman LK; Koziol DE; Morrow AL; Schiller CE; Cintron D; Thompson KD; Khine KK; Schmidt PJ
    Neuropsychopharmacology; 2016 Mar; 41(4):1093-102. PubMed ID: 26272051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of GABA active steroids in the female brain with a focus on the premenstrual dysphoric disorder.
    Bixo M; Johansson M; Timby E; Michalski L; Bäckström T
    J Neuroendocrinol; 2018 Feb; 30(2):. PubMed ID: 29072794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Women with premenstrual dysphoric disorder have altered sensitivity to allopregnanolone over the menstrual cycle compared to controls-a pilot study.
    Timby E; Bäckström T; Nyberg S; Stenlund H; Wihlbäck AN; Bixo M
    Psychopharmacology (Berl); 2016 Jun; 233(11):2109-2117. PubMed ID: 26960697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stress, mood, and cortisol during daily life in women with Premenstrual Dysphoric Disorder (PMDD).
    Beddig T; Reinhard I; Kuehner C
    Psychoneuroendocrinology; 2019 Nov; 109():104372. PubMed ID: 31357135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ESC/E(Z) complex, an effector of response to ovarian steroids, manifests an intrinsic difference in cells from women with premenstrual dysphoric disorder.
    Dubey N; Hoffman JF; Schuebel K; Yuan Q; Martinez PE; Nieman LK; Rubinow DR; Schmidt PJ; Goldman D
    Mol Psychiatry; 2017 Aug; 22(8):1172-1184. PubMed ID: 28044059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain reactivity during aggressive response in women with premenstrual dysphoric disorder treated with a selective progesterone receptor modulator.
    Kaltsouni E; Fisher PM; Dubol M; Hustad S; Lanzenberger R; Frokjaer VG; Wikström J; Comasco E; Sundström-Poromaa I
    Neuropsychopharmacology; 2021 Jul; 46(8):1460-1467. PubMed ID: 33927343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum brain-derived neurotrophic factor differences between the luteal and follicular phases in premenstrual dysphoric disorder.
    Oral E; Kirkan TS; Yildirim A; Kotan Z; Cansever Z; Ozcan H; Aliyev E; Gulec M
    Gen Hosp Psychiatry; 2015; 37(3):266-72. PubMed ID: 25799087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder.
    Girdler SS; Straneva PA; Light KC; Pedersen CA; Morrow AL
    Biol Psychiatry; 2001 May; 49(9):788-97. PubMed ID: 11331087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study.
    Epperson CN; Haga K; Mason GF; Sellers E; Gueorguieva R; Zhang W; Weiss E; Rothman DL; Krystal JH
    Arch Gen Psychiatry; 2002 Sep; 59(9):851-8. PubMed ID: 12215085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subgenual cingulate resting regional cerebral blood flow in premenstrual dysphoric disorder: differential regulation by ovarian steroids and preliminary evidence for an association with expression of ESC/E(Z) complex genes.
    Wei SM; Baller EB; Martinez PE; Goff AC; Li HJ; Kohn PD; Kippenhan JS; Soldin SJ; Rubinow DR; Goldman D; Schmidt PJ; Berman KF
    Transl Psychiatry; 2021 Apr; 11(1):206. PubMed ID: 33833224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder.
    Segebladh B; Borgström A; Nyberg S; Bixo M; Sundström-Poromaa I
    Am J Obstet Gynecol; 2009 Aug; 201(2):139.e1-8. PubMed ID: 19398092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The late-luteal leptin level, caloric intake and eating behaviors among women with premenstrual dysphoric disorder.
    Ko CH; Yen CF; Long CY; Kuo YT; Chen CS; Yen JY
    Psychoneuroendocrinology; 2015 Jun; 56():52-61. PubMed ID: 25800149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Menstrual Cycle and the Prevalence of Premenstrual Syndrome/Premenstrual Dysphoric Disorder in Adolescent Athletes.
    Czajkowska M; Drosdzol-Cop A; Gałązka I; Naworska B; Skrzypulec-Plinta V
    J Pediatr Adolesc Gynecol; 2015 Dec; 28(6):492-8. PubMed ID: 26233292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of premenstrual impairment among women undergoing prospective assessment for premenstrual dysphoric disorder: a cycle-level analysis.
    Schmalenberger KM; Eisenlohr-Moul TA; Surana P; Rubinow DR; Girdler SS
    Psychol Med; 2017 Jul; 47(9):1585-1596. PubMed ID: 28193300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mid-Luteal Progesterone Is Inversely Associated with Premenstrual Food Cravings.
    Hamidovic A; Soumare F; Naveed A; Davis J
    Nutrients; 2023 Feb; 15(5):. PubMed ID: 36904096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.